Connor, Clark & Lunn Investment Management Ltd. - HUTCHISON CHINA MEDITECH LTD ownership

HUTCHISON CHINA MEDITECH LTD's ticker is HCM and the CUSIP is 44842L103. A total of 69 filers reported holding HUTCHISON CHINA MEDITECH LTD in Q1 2023. The put-call ratio across all filers is 0.84 and the average weighting 0.0%.

Quarter-by-quarter ownership
Connor, Clark & Lunn Investment Management Ltd. ownership history of HUTCHISON CHINA MEDITECH LTD
ValueSharesWeighting
Q3 2023$443,980
+67.9%
26,209
+46.5%
0.00%0.0%
Q4 2022$264,399
+78.6%
17,889
+7.4%
0.00%
+100.0%
Q3 2022$148,000
-68.0%
16,664
+31.7%
0.00%
-50.0%
Q3 2021$463,00012,6520.00%
Other shareholders
HUTCHISON CHINA MEDITECH LTD shareholders Q1 2023
NameSharesValueWeighting ↓
Zeal Asset Management Ltd 2,339,885$93,421,00021.31%
UG Investment Advisers Ltd. 33,155$1,302,0002.52%
Pinz Capital Management, LP 159,400$6,260,0001.88%
Capital International Sarl 547,743$21,510,0001.86%
Capital International, Inc./CA/ 4,391,684$172,461,0001.54%
AIA Group Ltd 437,118$17,380,0001.20%
York Capital Management Global Advisors, LLC 182,297$7,159,0000.80%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 68,000$2,671,0000.70%
E Fund Management (Hong Kong) Co., Ltd. 18,579$730,0000.46%
M&G INVESTMENT MANAGEMENT LTD 4,512,562$175,990,0000.44%
View complete list of HUTCHISON CHINA MEDITECH LTD shareholders